Previous Article | Next Article 
Journal of Clinical Microbiology, May 2006, p. 1726-1732, Vol. 44, No. 5
0095-1137/06/$08.00+0 doi:10.1128/JCM.44.5.1726-1732.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Multilaboratory Comparison of Hepatitis C Virus Viral Load Assays
A. M. Caliendo,1*
A. Valsamakis,2
Y. Zhou,3
B. Yen-Lieberman,4
J. Andersen,3
S. Young,5
A. Ferreira-Gonzalez,6
G. J. Tsongalis,7
R. Pyles,8
J. W. Bremer,9 and
N. S. Lurain9
Emory University School of Medicine, Atlanta, Georgia,1
The Johns Hopkins Medical Institutions, Baltimore, Maryland,2
Harvard School of Public Health, Boston, Massachusetts,3
Cleveland Clinic Foundation, Cleveland, Ohio,4
Tricore Reference Laboratories, Albuquerque, New Mexico,5
Virginia Commonwealth University, Richmond, Virginia,6
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire,7
University of Texas Medical Branch, Galveston, Texas,8
Division of AIDS Viral Quality Assurance Laboratory Viral Quality Assessment Laboratory, Rush University Medical Center, Chicago, Illinois9
Received 21 December 2005/
Returned for modification 31 January 2006/
Accepted 8 March 2006
We report a multilaboratory evaluation of hepatitis C virus (HCV) viral load assays to determine their linear range, reproducibility, subtype detection, and agreement. A panel of HCV RNA samples ranging in nominal concentration from 1.0 to 7.0 log10 IU/ml was constructed by diluting a clinical specimen (genotype 1b). Replicates of the panel were tested in multiple laboratories using the Abbott TaqMan analyte-specific reagent (Abbott reverse transcription-PCR [RT-PCR]), Roche TaqMan RUO (Roche RT-PCR), Roche Amplicor Monitor HCV 2.0 (Roche Monitor), and Bayer VERSANT HCV RNA 3.0 (Bayer bDNA) assays. Bayer bDNA-negative specimens were tested reflexively using the Bayer VERSANT HCV RNA qualitative assay (Bayer TMA). Abbott RT-PCR and Roche RT-PCR detected all 28 replicates with a concentration of 1.0 log10 IU/ml and were linear to 7.0 log10 IU/ml. Roche Monitor and Bayer bDNA detected 27 out of 28 and 13 out of 28 replicates, respectively, of 3.0 log10 IU/ml. Bayer TMA detected all seven replicates with 1.0 log10 IU/ml. Bayer bDNA was the most reproducible of the four assays. The mean viral load values for panel members in the linear ranges of the assays were within 0.5 log10 for the different tests. Eighty-nine clinical specimens of various genotypes (1 through 4) were tested in the Bayer bDNA, Abbott RT-PCR, and Roche RT-PCR assays. For Abbott RT-PCR, mean viral load values were 0.61 to 0.96 log10 greater than the values for Bayer bDNA assay for samples with genotype 1, 2, or 3 samples and 0.08 log10 greater for genotype 4 specimens. The Roche RT-PCR assay gave mean viral load values that were 0.28 to 0.82 log10 greater than those obtained with the Bayer bDNA assay for genotype 1, 2, and 3 samples. However, for genotype 4 samples the mean viral load value obtained with the Roche RT-PCR assay was, on average, 0.15 log10 lower than that of the Bayer bDNA. Based on these data, we conclude that the sensitivity and linear range of the Abbott and Roche RT-PCR assays enable them to be used for HCV diagnostics and therapeutic monitoring. However, the differences in the viral load values obtained with the different assays underscore the importance of using one assay when monitoring response to therapy.
* Corresponding author. Mailing address: Clinical Laboratories, H180, Emory University Hospital, 1364 Clifton Rd., Atlanta, GA 30322. Phone: (404) 712-5721. Fax: (404) 727-3133. E-mail:
acalien{at}emory.edu.
Journal of Clinical Microbiology, May 2006, p. 1726-1732, Vol. 44, No. 5
0095-1137/06/$08.00+0 doi:10.1128/JCM.44.5.1726-1732.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Pyne, M. T., Konnick, E. Q., Phansalkar, A., Hillyard, D. R.
(2009). Evaluation of the Abbott Investigational Use Only RealTime Hepatitis C Virus (HCV) Assay and Comparison to the Roche TaqMan HCV Analyte-Specific Reagent Assay. J. Clin. Microbiol.
47: 2872-2878
[Abstract]
[Full Text]
-
Mulligan, E. K., Germer, J. J., Arens, M. Q., D'Amore, K. L., Di Bisceglie, A., Ledeboer, N. A., Moser, M. J., Newman, A. C., O'Guin, A. K., Olivo, P. D., Podzorski, D. S., Vaughan, K. A., Yao, J. D., Elagin, S. A., Johnson, S. C.
(2009). Detection and Quantification of Hepatitis C Virus (HCV) by MultiCode-RTx Real-Time PCR Targeting the HCV 3' Untranslated Region. J. Clin. Microbiol.
47: 2635-2638
[Abstract]
[Full Text]
-
Vermehren, J., Kau, A., Gartner, B. C., Gobel, R., Zeuzem, S., Sarrazin, C.
(2008). Differences between Two Real-Time PCR-Based Hepatitis C Virus (HCV) Assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and One Signal Amplification Assay (Versant HCV RNA 3.0) for RNA Detection and Quantification. J. Clin. Microbiol.
46: 3880-3891
[Abstract]
[Full Text]
-
Forman, M. S., Valsamakis, A.
(2008). Performance Characteristics of a Quantitative Hepatitis C Virus RNA Assay Using COBAS AmpliPrep Total Nucleic Acid Isolation and COBAS TaqMan Hepatitis C Virus Analyte-Specific Reagent. J. Mol. Diagn.
10: 147-153
[Abstract]
[Full Text]
-
Laperche, S., Bouchardeau, F., Thibault, V., Pozzetto, B., Vallet, S., Rosenberg, A. R., Roque-Afonso, A.-M., Gassin, M., Stoll-Keller, F., Trimoulet, P., Gault, E., Chanzy, B., Mercier, B., Branger, M., Pawlotsky, J.-M., Henquell, C., Lunel, F., Gaudy-Graffin, C., Alain, S., Chaix, M.-L., Duverlie, G., Izopet, J., Lefrere, J.-J.
(2007). Multicenter Trials Need To Use the Same Assay for Hepatitis C Virus Viral Load Determination. J. Clin. Microbiol.
45: 3788-3790
[Abstract]
[Full Text]
-
Tuaillon, E., Mondain, A.-M., Ottomani, L., Roudiere, L., Perney, P., Picot, M.-C., Seguret, F., Blanc, F., Larrey, D., Van de Perre, P., Ducos, J.
(2007). Impact of Hepatitis C Virus (HCV) Genotypes on Quantification of HCV RNA in Serum by COBAS AmpliPrep/COBAS TaqMan HCV Test, Abbott Antiretroviral Therapy HCV RealTime Assay, and VERSANT HCV RNA Assay. J. Clin. Microbiol.
45: 3077-3081
[Abstract]
[Full Text]
-
Fan, Z., Huang, X.-L., Kalinski, P., Young, S., Rinaldo, C. R. Jr.
(2007). Dendritic Cell Function during Chronic Hepatitis C Virus and Human Immunodeficiency Virus Type 1 Infection. CVI
14: 1127-1137
[Abstract]
[Full Text]
-
Sabato, M. F., Shiffman, M. L., Langley, M. R., Wilkinson, D. S., Ferreira-Gonzalez, A.
(2007). Comparison of Performance Characteristics of Three Real-Time Reverse Transcription-PCR Test Systems for Detection and Quantification of Hepatitis C Virus. J. Clin. Microbiol.
45: 2529-2536
[Abstract]
[Full Text]
-
Schutten, M., Peters, D., Back, N. K. T., Beld, M., Beuselinck, K., Foulongne, V., Geretti, A.-M., Pandiani, L., Tiemann, C., Niesters, H. G. M.
(2007). Multicenter Evaluation of the New Abbott RealTime Assays for Quantitative Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNA. J. Clin. Microbiol.
45: 1712-1717
[Abstract]
[Full Text]
-
Caliendo, A. M., Ingersoll, J., Fox-Canale, A. M., Pargman, S., Bythwood, T., Hayden, M. K., Bremer, J. W., Lurain, N. S.
(2007). Evaluation of Real-Time PCR Laboratory-Developed Tests Using Analyte-Specific Reagents for Cytomegalovirus Quantification. J. Clin. Microbiol.
45: 1723-1727
[Abstract]
[Full Text]